HOME >> BIOLOGY >> NEWS
Special issue of the Journal of Industrial Ecology focuses on eco-efficiency

Disputes over the trade-off between the environment and the economy are a central feature of contemporary politics. Whether the threat is global warming or toxic substances, the tension between cost and environmental benefit is often palpable.

Some of these disagreements can be avoided through better understanding of eco-efficiency--the actual value of an investment or expenditure on environmental improvements. Eco-efficiency is the focus of a special issue of Yale's Journal of Industrial Ecology, which offers path-breaking analysis of this key concept.

"Through calculations of eco-efficiency, our grasp of the relationship between cost and environmental value can be sharpened," said Gus Speth, Dean of the School of Forestry & Environmental Studies at Yale. "The research in this issue represents a major advance in this important tool."

Articles in the special issue examine how eco-efficiency can be used as a practical tool for analysis and as a framework for making difficult choices. The eco-efficiency of activities and choices--for production and consumption, and even for economic sectors and regions--can be quantified. Central developments described in this special issue include less-contested ways to quantify the environmental impact of activities, with articles on data envelopment analysis and the maximum abatement cost method.

"This special issue demonstrates the power of industrial ecology," says Reid Lifset, editor-in-chief of the Journal. "Concepts that lie at the core of this field, such as dematerialization, design-for-environment and life-cycle management, can be consistently combined with economic analysis, helping us to understand much better the pivotal role the economy-environment tradeoff plays in shaping the quality of our environment."

Using these techniques, journal contributors examined eco-efficiency in small businesses in South Korea; in the UK steel and aluminum industries; of a region in Finland; of d
'"/>

Contact: Reid J. Lifset
indecol@yale.edu
203-432-6949
Yale University
16-Mar-2006


Page: 1 2

Related biology news :

1. Specialized, bone-crushing wolves of Alaska disappeared long ago
2. Special ES&T issue examines effects of emerging contaminants on people, planet
3. Special chip provides better picture of salmon health
4. Special Science issue examines HIV/AIDS in Latin America and the Caribbean
5. Fulbright awards Senior Specialist grant to Carnegies Marilyn Fogel
6. Media alert: Special session on the impact of Hurricanes Katrina, Rita on crops, soils, environment
7. Media alert: Special sessions feature Utahs military, agriculture connections
8. Specialized immune-system B cells play double-barreled role
9. Special issue links genetics and environment in aging studies
10. Hospital for Special Surgerys Boskey named AAAS fellow
11. First case of successful ovarian tissue transplantation between two, nonidentical sisters

Post Your Comments:
(Date:5/6/2015)... 6, 2015 LifeBEAM, a developer of bio-sensing ... announced today that they will expand their partnership in ... bio-sensing cycling helmet and the first joint project between ... colors in order to give cyclists more style choices ... LifeBEAM and Lazer announced their plan to release a ...
(Date:4/21/2015)... 21, 2015 High crime ... are boosting access control systems market in ... a recently published report by TechSci Research " Saudi ... access control systems market in Saudi Arabia ... 2020.The access control systems market in the Kingdom is ...
(Date:4/14/2015)... Conn. , April 14, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... been nominated for the 2015 New York Design Awards ... The Design100, New York City Design Awards are part ... based on over 2,500 ratings from the marketplace, industry ...
Breaking Biology News(10 mins):LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
(Date:5/22/2015)... 2015 Knowledgent , the data ... explores the potential of big data analytics in the ... developed to help life sciences and healthcare organizations understand ... gain critical business insights. , The life sciences and ... driven by patient profiling, compliance and regulatory requirements, and ...
(Date:5/21/2015)... Specialty Pharmacy Times has completed ... to BPA Worldwide as a business publication member. ... data for Specialty Pharmacy Times based on business/distribution, ... a member of BPA Worldwide, Specialty Pharmacy Times ... with the most reliable, unequaled data,” said Chris ...
(Date:5/21/2015)... May 21, 2015  The EveryLife Foundation for ... (R-UT) and Amy Klobuchar (D-MN) today ... Cures & Treatments, or OPEN ACT. ... advocacy organizations, this bipartisan legislation promises to rapidly ... to rare disease patients by incentivizing drug makers ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
Breaking Biology Technology:New White Paper Explores the Potential of Big Data Analytics in Life Sciences and Healthcare 2Specialty Pharmacy Times Joins BPA Worldwide 2Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7
Cached News: